Background: Sepsis is a critical and urgent infectious condition in clinical practice, traditionally diagnosed through blood culture, which identifies the presence (either suspected or confirmed) of infection along with systemic signs of an inflammatory response1,2,3. Objective: To analyse the microbial spectrum among culture-positive sepsis patients admitted to the medicine ward. Methods: This observational study was conducted over six months at Assam Medical College and Hospital, including 80 adult sepsis patients. Culture-positive cases were analysed for type of infection and organism isolated. Results: Of the 80 patients, 47 (58.75%) were culture-positive. Gram-negative organisms predominated, with Escherichia coli (25.53%), Klebsiella pneumoniae (17.02%), and Staphylococcus aureus (14.9%) as the most common isolates. Blood, urine, sputum, wound, and other body fluid cultures contributed to pathogen identification. Conclusion: Gram-negative bacteria were the most frequent pathogens in culture-positive sepsis, reflecting the importance of early empirical antimicrobial coverage targeting these organisms.
The identification of causative microorganisms in sepsis plays a vital role in patient management and prognosis. Sepsis can result from a broad spectrum of bacterial and fungal pathogens, each with varying degrees of antimicrobial resistance. As highlighted in previous studies, including the work by Vendemiato et al5 common causative agents include Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae, and multidrug-resistant organisms such as Acinetobacter baumannii and methicillin-resistant Staphylococcus aureus (MRSA). Accurate microbiological identification not only facilitates targeted antimicrobial therapy but also helps curb the inappropriate use of broad-spectrum antibiotics, which contributes to resistance. Given that early and appropriate antibiotic intervention significantly reduces mortality in sepsis, microbiological confirmation through blood culture remains an essential diagnostic and therapeutic tool in clinical practice.
Study Site: Department of General Medicine, Assam Medical College and Hospital.
Study Design: A hospital-based observational study.
Study Duration: 6 months (January 2024 to June 2024)
Study population: Considering the prevalence (P) of sepsis cases in India6 to be 28.3% and taking absolute error (d) of 10% with 95% confidence interval, the sample size calculated is 78 which is then rounded off to obtain the final sample size of 80. The purpose of the study was explained and informed consent was obtained from parents or patients in vernacular language.
Inclusion Criteria:
Exclusion Criteria:
Data Collection: Patients fulfilling the inclusion criteria were included in the study. Demographic data with detailed history and clinical examination were done along with routine investigations for the diagnosis of sepsis.
Blood samples collected under aseptic conditions were inoculated immediately into the blood culture bottle (aerobic blood culture bottle). Once received in the microbiology laboratory, the blood culture bottles were loaded into the BACTALERT-480 Automated blood culture system. The bacterial isolates were identified from the positive vial by gram stain, colony morphology on blood agar, chocolate agar, and MacConkey agar, and by standard biochemical tests4.
Ethical statement: Ethical clearance was obtained from the Institutional Ethics Committee (IEC) of Assam Medical College and Hospital (Human)
Statistical Analysis: Data were analysed using SPSS v20. Continuous variables were expressed as mean ± SD and compared using the Students’ t-test. Categorical variables were expressed as numbers and percentages and compared using the chi-square test. A p-value <0.05 was considered statistically significant.
Table -1: Gender Distribution
Gender |
Number |
Percentage |
Male |
49 |
61.25 |
Female |
31 |
38.75 |
TOTAL |
80 |
100.00 |
Ratio (Male: Female) |
1. 58: 1 |
Table -2: Age wise distribution
Age Group |
Number |
Percentage |
18–20 |
2 |
2.50 |
21–30 |
6 |
7.50 |
31–40 |
10 |
12.50 |
41–50 |
29 |
36.25 |
51–60 |
18 |
22.50 |
61–70 |
11 |
13.75 |
>70 |
4 |
5.00 |
TOTAL |
80 |
100.00 |
Mean ± S.D. |
48.58 |
13.00 |
Table-3: Distribution of study subjects by types of primary disease on presentation
Disease/ Diagnosis |
Number |
Percentage |
Respiratory tract infections |
22 |
27.5 |
Urinary tract infections |
16 |
20 |
Acute encephalitis syndrome |
13 |
16.2 |
Endocarditis |
9 |
11.3 |
GIT |
9 |
11.3 |
Miscellaneous |
11 |
13.7 |
TOTAL |
80 |
100.0 |
Table–4: Status of Body Fluid Cultures
Cultures |
Number(n) |
Percentage(%) |
Negative |
33 |
41.25 |
Positive |
47 |
58.75 |
TOTAL |
80 |
100.00 |
Table–4: Positive Culture
Culture |
Number |
Percentage |
Blood |
9 |
19.14 |
Csf |
2 |
4.26 |
Urine |
12 |
25.53 |
Wound |
4 |
8.5 |
Pleural fluid |
6 |
12.77 |
Sputum |
10 |
21.3 |
Others |
4 |
8.5 |
TOTAL |
47 |
100 |
Table–5: Causative organism in cultures
Culture |
Number |
Percentage |
No growth |
33 |
41.25 |
Escherichia coli |
12 |
25.53 |
Klebsiella pneumoniae |
8 |
17.02 |
Klebsiella oxytoca |
5 |
10.64 |
Acinetobacter baumannii |
2 |
4.25 |
Pseudomonas |
3 |
6.38 |
Staph aureus |
7 |
14.9 |
Pneumococci |
6 |
12.77 |
Enterobacter |
4 |
8.51 |
The study reveals that respiratory tract infections (27.5%) and urinary tract infections (20%) were the most common presenting illnesses, followed by acute encephalitis syndrome (16.2%) and endocarditis (11.3%). Correspondingly, urine (25.53%) and sputum (21.3%) were the most frequent positive culture sources, reflecting the clinical burden of urinary and respiratory infections. Blood cultures accounted for 19.14%, highlighting the importance of bloodstream infections, while CSF and pleural fluid contributed smaller proportions.
Regarding the cultures, a major proportion of cultures (41.25%) showed no growth, which may reflect prior antibiotic use, inadequate sample collection, or the presence of fastidious organisms not detected by routine culture methods.
Among the positive cultures, Escherichia coli was the most frequently isolated organism (25.53%), consistent with its well-established role as a predominant pathogen in both community-acquired and healthcare-associated infections, particularly urinary tract and bloodstream infections7.
Klebsiella pneumoniae (17.02%) and Klebsiella oxytoca (10.64%) were also common isolates, highlighting the increasing clinical significance of Klebsiella species, which are often associated with multidrug resistance and extended-spectrum beta-lactamase (ESBL) production8.
The detection of Staphylococcus aureus in 14.9% of cultures, including the possibility of methicillin-resistant strains, highlights its importance in both skin/soft tissue and invasive infections8.
Pseudomonas spp. (6.38%) and Acinetobacter baumannii (4.25%), though less frequent, are of particular concern due to their intrinsic resistance mechanisms and their association with nosocomial infections, especially in critically ill patients9. The isolation of Pneumococci (12.77%) reflects the burden of community-acquired respiratory infections, while Enterobacter spp. (8.51%) further adds to the complexity of gram-negative infections encountered in clinical practice.
The presence of multidrug-resistant organisms like Acinetobacter baumannii and Pseudomonas spp. is of high concern as it makes treatment a significant challenge. This calls for strict antimicrobial stewardship and infection control measures. The high rate of no-growth cultures emphasizes the need to improve sample collection and consider advanced diagnostics. Regular surveillance of microbial patterns is essential to guide effective treatment strategies.
Declaration of Interests: There are no conflicts of interest.